Are Prospective Studies Too Challenging to Execute for Timing of Resuming Anticoagulation After ICH in Patients With Mechanical Heart Valves?

Neurology. 2024 Aug 27;103(4):e209772. doi: 10.1212/WNL.0000000000209772. Epub 2024 Aug 5.

Authors

Lourdes Carhuapoma¹, Wen D Zhan¹, Wendy C Ziai¹, Daniel F Hanley¹, Vishank Shah¹

Affiliation

¹ From the Division of Neurosciences Critical Care (L.C.), The Johns Hopkins Hospital, Baltimore; Division of Brain Injury Outcomes, Department of Neurology (W.D.Z., D.F.H.) and Division of Neurosciences Critical Care Medicine, Departments of Neurology, Neurosurgery, and Anesthesiology and Critical Care Medicine (W.C.Z., V.S.), Johns Hopkins University School of Medicine, Baltimore, MD.

PMID: 39102618
DOI: 10.1212/WNL.0000000000209772

No abstract available

Publication types

Editorial

MeSH terms

Anticoagulants* / administration & dosage
Anticoagulants* / adverse effects
Anticoagulants* / therapeutic use
Heart Valve Prosthesis* / adverse effects
Humans
Intracranial Hemorrhages / chemically induced
Prospective Studies
Time Factors

Substances

Anticoagulants